الجمعة 12 جمادى الأولى 1448هـ
جميع روابط المواقع الرسمية التابعة للجهات الحكومية في المملكة العربية السعودية تنتهي بـ .gov.sa
تحقق من أن الموقع يستخدم بروتوكول HTTPS
مسجل لدى هيئة الحكومة الرقمية برقم :
| عنوان الدراسة | داعم الدراسة | حالة الدراسة | دواء الدراسة | مرحلة الدراسة | رقم بروتوكول الدراسة | موقع الدراسة |
|---|---|---|---|---|---|---|
| A 12-week, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of QAW039 when added to standard-of-care asthma therapy in patients with uncontrolled asthma | Novartis | Completed | QAW039/Fevipiprant | 3 | CQAW039A2316 | KFMC |
| "RAINBOW extension study: an extension study to evaluate the long term efficacy and safety of RAnibizumab compared with laser therapy for the treatment of Infants BOrn prematurely With retinopathy of prematurity" | 3 | |||||
| Use of high dose of Colistin in Multidrug Resistant Gram Negative infections. Randomized Controlled clinical Trial | King Saud Medical City | Completed | Colistin | 4 | KSMC-12-13 | King Saud Medical City |
| "easypod connect: A regional, Multicentre, Observational study to evaluate Adherenceand Long Term Outcomes of Therapy in Paediatric subjects using “easypodTM” electromechanical device for growth hormone treatment" | Merck Serono | Rejected | - | 4 | 200104-534 | King Khalid University Hospital (Riyadh) |
| "AN OBSERVATIONAL, NON-INTERVENTIONAL,MULTI-CENTER, MULTI-NATIONAL STUDY OFPATIENTS WITH ATYPICAL HEMOLYTIC-UREMICSYNDROME(AHUS REGISTRY)" | Alexion | Rejected | - | 4 | M11-001 | N/A |
| A Phase IV Double-Blind Placebo-Controlled Randomized Clinical Trial Assessing the Effect of 2 month consumption of Vetal Laban Including Lactobacillus acidophilus NCFM on Functional Gastrointestinal Symptoms Among Subjects Fulfilling Rome III Criteria for A Phase IV, Randomized, double-blind, placebo-controlled study with parallel groups Irritable Bowel Syndrome | Almarai | Rejected | Vetal Laban containing Lactobacillus acidophilus NCFM at 1.6 x 109 CFU per container | 4 | IBS - 0920 | King Fahad Medical City (Riyadh) |
| "An Open-label, Multicentre, Randomised, 2-arm Study to Investigate the Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose Versus Oral Iron for the Treatment of Iron Deficiency Anaemia in Pregnant Women" | Vifor Pharma | Terminated | Ferrous Sulphate + Ferinject | 3 | FER-ASAP-2009-01 | King Faisal Specialist Hospital and Research Center (Riyadh) |
| The Effectiveness of Convalescent Plasma for the Treatment of Severe COVID-19 Cases in Intensive Care Unit | King Faisal Specialist Hospital and Research Centre | Ongoing | Convalescent Plasma | 3 | IRB 2020-19-V2 | King Faisal Specialist Hospital and Research Center (Jeddah) |
| An Open Label, Phase IV, Multi-Centric, Prospective, Single Arm Study to Assess the Safety and Efficacy of Dexaflox Eye Drops Containing Ofloxacin (3 mg) and dexamethasone (1 mg) in Subjects with Bacterial Conjunctivitis | Jamjoom Pharmaceuticals | Completed | Dexaflox | 4 | DEXA001 | King Khalid University Hospital (Riyadh) |
| An Open Label, Phase IV, Multi-Centric, Prospective, Single Arm Study to Assess the Safety and Efficacy of Loxtra Eye Drops Containing Ofloxacin (3 mg), Prednisolone (2 mg) and Tetrahydrozoline Hydrochloride (0.4 mg) in Subjects with Bacterial Conjunctivitis and Other Ocular Inflammatory Conditions | Jamjoom Pharmaceuticals | Completed | Loxtra | 4 | LOX001 | King Khalid University Hospital (Riyadh) |
تاريخ آخر تحديث: 06/10/2026 بتمام الساعة 08:14 صباحا بتوقيت المملكة العربية السعودية
لم يتم تقديم أي تقييمات لهذه الصفحة بعد.
التعليقات والاقتراحات
لأي استفسارات أو ملاحظات حول الخدمات الحكومية، يرجى تعبئة المعلومات المطلوبة.